A
Anne L. Rosenberg
Researcher at Thomas Jefferson University
Publications - 49
Citations - 7738
Anne L. Rosenberg is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 28, co-authored 49 publications receiving 7367 citations. Previous affiliations of Anne L. Rosenberg include Thomas Jefferson University Hospital.
Papers
More filters
Journal ArticleDOI
MicroRNA gene expression deregulation in human breast cancer.
Marilena V. Iorio,Manuela Ferracin,Chang Gong Liu,Angelo Veronese,Riccardo Spizzo,Silvia Sabbioni,Eros Magri,Massimo Pedriali,Muller Fabbri,Manuela Campiglio,Sylvie Ménard,Juan P. Palazzo,Anne L. Rosenberg,Piero Musiani,Stefano Volinia,Italo Nenci,George A. Calin,Patrizia Querzoli,Massimo Negrini,Carlo M. Croce +19 more
TL;DR: It is shown that, compared with normal breast tissue, miRNAs are also aberrantly expressed in human breast cancer, and the overall miRNA expression could clearly separate normal versus cancer tissues, with the most significantly deregulated mi RNAs being mir-125b, mir-145, mir -21, and mir-155.
Journal ArticleDOI
Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database.
Gloria J. Morris,Sashi Naidu,Allan Topham,Fran Guiles,Yihuan Xu,Peter McCue,Gordon F. Schwartz,Pauline K. Park,Anne L. Rosenberg,Kristin Brill,Edith P. Mitchell +10 more
TL;DR: Breast carcinomas in African–American patients appear to be more aggressive than in Caucasian patients due to multifactorial differences, and these differences may be related to race, ethnicity, or both.
Journal ArticleDOI
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets.
Raffaele Baffa,Matteo Fassan,Matteo Fassan,Stefano Volinia,Brian J. O'Hara,Chang Gong Liu,Juan P. Palazzo,Marina Paola Gardiman,Massimo Rugge,Leonard G. Gomella,Carlo M. Croce,Anne L. Rosenberg +11 more
TL;DR: The results suggest that specific miRNAs may be directly involved in cancer metastasis and that they may represent a novel diagnostic tool in the characterization of metastatic cancer gene targets.
Journal ArticleDOI
Reprogramming of miRNA networks in cancer and leukemia
Stefano Volinia,Marco Galasso,Stefan Costinean,Luca Tagliavini,Giacomo Gamberoni,Alessandra Drusco,Jlenia Marchesini,Nicoletta Mascellani,Maria Elena Sana,Ramzey Abu Jarour,Caroline Desponts,Michael A. Teitell,Raffaele Baffa,Rami I. Aqeilan,Marilena V. Iorio,Cristian Taccioli,Ramiro Garzon,Gianpiero Di Leva,Muller Fabbri,Marco Catozzi,Maurizio Previati,Stefan Ambs,Tiziana Palumbo,Michela Garofalo,Angelo Veronese,Arianna Bottoni,Pierluigi Gasparini,Curtis C. Harris,Rosa Visone,Yuri Pekarsky,Albert de la Chapelle,Mark Bloomston,Mary Dillhoff,Laura Z. Rassenti,Thomas J. Kipps,Kay Huebner,Flavia Pichiorri,Dido Lenze,Stefano Cairo,Marie Annick Buendia,Pascal Pineau,Anne Dejean,Nicola Zanesi,Simona Rossi,George A. Calin,Chang Gong Liu,Jeff Palatini,Massimo Negrini,Andrea Vecchione,Anne L. Rosenberg,Carlo M. Croce +50 more
TL;DR: In this paper, the authors studied miRNA profiles in 4419 human samples (3312 neoplastic, 1107 nonmalignant), corresponding to 50 normal tissues and 51 cancer types.
Journal ArticleDOI
Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy.
Carl M. Mansfield,Lydia Komarnicky,Gordon F. Schwartz,Anne L. Rosenberg,Leela Krishnan,William R. Jewell,Francis E. Rosato,Melvin L. Moses,Mahroo Haghbin,Janet Taylor +9 more
TL;DR: Patients treated conservatively for Stages I and II breast cancer between the years 1982 and 1994 were reviewed and the median follow‐up was 40 months with a maximum follow-up of 152 months.